Non-hormonal male contraceptive implant lasts at least two years in trials
Guardian2 days
Novel Male Birth Control Shows 2-Year Effectiveness in Trial
Above: Technical platform of the Inovie 34 laboratory. Image copyright: TREMELET/Contributor/IMAGE POINT FR/BSIP/Universal Images Group via Getty Images
The Spin
Narrative A
Contraline's successful clinical trials are a medical breakthrough. The Phase 1 study demonstrated that ADAM is effective for up to 24 months and safe, with no serious adverse effects or unexpected medical concerns. If the Phase 2 clinical trials and beyond prove just as successful, Contraline could make a generational leap forward in contraceptive medicine.
Narrative B
While Contraline's Phase 1 results are promising, significant questions remain unanswered concerning ADAM. Presently, there is no data to clarify just how long an ADAM implant lasts, no evidence to show if it can be removed, and no insight into what side effects a long-term blockage of the vas deferens could have. For ADAM to be successful, Contraline must answer these important questions.